Full Text
DAPAGLIFLOZIN- COST EFFECTIVENESS AS AN ADD-ON THERAPY TO METFORMIN IN THE TREATMENT OF TYPE 2 DIABETES IN ECUADOR

Abstract

Authors

J.F. Elgart M. Prestes L. Gonzalez C. Solis Sanchez W. Acosta J. Solorzano J.J. Gagliardino

Back to Volume 19, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×